Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic Non Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04188678
What this trial is testing

Resiliency in Older Adults Undergoing Bone Marrow Transplant

Who this might be right for
LeukemiaLymphomaBlood Cancer+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 126
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Not applicableEnded earlyNCT00578461
What this trial is testing

T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE

Who this might be right for
LeukemiaCancerLymphoma+2 more
Baylor College of Medicine 26
Testing effectiveness (Phase 2)Study completedNCT00719888
What this trial is testing

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more
Fred Hutchinson Cancer Center 135
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableLooking for participantsNCT01890486
What this trial is testing

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Wake Forest University Health Sciences 2,000
Not applicableEnded earlyNCT00005786
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic Leukemia+8 more
National Cancer Institute (NCI) 25
Not applicableUnknownNCT03302403
What this trial is testing

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Who this might be right for
B Cell LymphomaB Cell LeukemiaMyeloma+3 more
Kang YU 18
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Not applicableStudy completedNCT07689006
What this trial is testing

Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Bristol-Myers Squibb 341
Not applicableStudy completedNCT04036448
What this trial is testing

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

Who this might be right for
Myelodysplastic SyndromesLymphoma, Mantle-CellLymphoma, Follicular
Celgene 28
Large-scale testing (Phase 3)Study completedNCT00507416
What this trial is testing

Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 502
Large-scale testing (Phase 3)Study completedNCT00145652
What this trial is testing

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Who this might be right for
AnemiaMultiple MyelomaNon Hodgkin Lymphoma+1 more
Sundsvall Hospital 66
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Large-scale testing (Phase 3)Looking for participantsNCT05254743
What this trial is testing

Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemia, LymphocyticLeukemia, B-cell+1 more
Loxo Oncology, Inc. 737
Early research (Phase 1)Study completedNCT01534715
What this trial is testing

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Lymphoma, Non-HodgkinChronic Lymphocytic Leukemia
ImmunoGen, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT01532635
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Who this might be right for
Hematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Testing effectiveness (Phase 2)Study completedNCT00238433
What this trial is testing

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 37
Early research (Phase 1)UnknownNCT04007978
What this trial is testing

Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies

Who this might be right for
B Cell LymphomaAcute Lymphoblastic Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Early research (Phase 1)Study completedNCT00348985
What this trial is testing

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55
Next Page